Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Oliver Koivisto"'
Autor:
Wenhui Zhou, Xiaodong Ma, Jie Wang, Xiaoyu Xu, Oliver Koivisto, Jing Feng, Tapani Viitala, Hongbo Zhang
Publikováno v:
Smart Medicine, Vol 1, Iss 1, Pp n/a-n/a (2022)
Abstract Triple‐negative breast cancer (TNBC) is still the most aggressive cancer in women. Combination chemotherapy holds great potential for cancer therapy; however, the off‐target and side effects of free chemotherapy administration remain a m
Externí odkaz:
https://doaj.org/article/4dce4e1202314c48a16761dd3e647655
Autor:
Xiaoyu Xu, Chang Liu, Shengyi Wang, Ermei Mäkilä, Jiali Wang, Oliver Koivisto, Junnian Zhou, Jessica M. Rosenholm, Yilai Shu, Hongbo Zhang
Publikováno v:
Nanoscale. 14(42)
Ribonucleoprotein (RNP) based CRISPR/Cas9 gene-editing system shows great potential in biomedical applications. However, due to the large size, charged surface and high biological sensitivity of RNP, its efficient delivery with precise control remain
Autor:
Oliver Koivisto, Jessica M. Rosenholm, Xiaoyu Xu, Wenhui Zhou, Chang Liu, Hongbo Zhang, Guillaume Jacquemet
Publikováno v:
Nanoscale. 13:16525-16532
Appropriate tuning of robust artificial coatings can not only enhance intracellular delivery but also preserve the biological functions of genetic molecules in gene based therapies. Here, we report a strategy to synthesize controllable nanostructures
Publikováno v:
Advanced Drug Delivery Reviews. 176:113891
CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats-associated protein 9) is a potent technology for gene-editing. Owing to its high specificity and efficiency, CRISPR/Cas9 is extensity used for human diseases treatment, especially
Autor:
Guillaume Jacquemet, Xiaoyu Xu, Hongbo Zhang, Chang Liu, Jessica M. Rosenholm, Junnian Zhou, Yilai Shu, Mitro Miihkinen, Daqi Wang, Oliver Koivisto
Publikováno v:
Advanced Therapeutics. 4:2000072